12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target
Objectives Gout is often not adequately treated, and we aimed to apply urate lowering treatment (ULT) combined with individual information to achieve target serum urate (sUA) in clinical practice, and to identify predictors of achievement of this sUA target.Methods Patients with a recent gout flare...
Main Authors: | Till Uhlig, Espen A Haavardsholm, Lars F Karoliussen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-04-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/7/1/e001628.full |
Similar Items
-
Treat-to-target (T2T) of serum urate (SUA) in gout: a clinical audit in real-world gout patients
by: C.L. Teh, et al.
Published: (2019-10-01) -
Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
by: Dalbeth Nicola, et al.
Published: (2012-09-01) -
Variation in serum urate levels in the absence of gout and urate lowering therapy
by: Andrew Shaffer, et al.
Published: (2021-09-01) -
Systemic Urate Deposition: An Unrecognized Complication of Gout?
by: Puja Khanna, et al.
Published: (2020-10-01) -
Sonographic estimation of monosodium urate burden predicts the fulfillment of the 2016 remission criteria for gout: a 12-month study
by: Edoardo Cipolletta, et al.
Published: (2021-07-01)